Approval · Notice of Compliance 37663 · 2026
SLYND: Notice of Compliance 37663
Issued June 4, 2026
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 37663
- Date
- June 4, 2026
- Company
- Duchesnay Inc.Blainville, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Change in the manufacturing process for the drug substance. Change in the specification for the drug substance
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| SLYND | Not yet assigned | — |
Medicinal ingredients
- DROSPIRENONE 4 MG per TAB